Related Experiment Videos
Lathyrogenic agents as therapy for subglottic stenosis--a pilot study.
1Department of Otolaryngology-Head and Neck Surgery, University of Illinois, Chicago 60612.
Summary
Lathyrogenic agents, penicillamine and N-acetyl-L-cysteine, show promise in preventing subglottic stenosis (SGS) recurrence after surgical repair in a canine model. These compounds may offer a new adjunctive therapy for human SGS treatment.
Area of Science:
- Otolaryngology
- Regenerative Medicine
- Pharmacology
Background:
- Subglottic stenosis (SGS) surgical repair often fails due to scar contracture recurrence.
- Lathyrogenic agents, inhibiting collagen cross-linking, successfully prevented stenosis in esophageal burn models.
- Application of lathyrism principles to laryngotracheal stenosis treatment remained unexplored.
Purpose of the Study:
- To evaluate the efficacy of penicillamine and N-acetyl-L-cysteine in reducing subglottic stenosis reformation.
- To test the application of lathyrogenic agents in a canine model of experimentally induced SGS.
- To assess the potential of these agents as adjunctive therapy for surgical management of SGS.
Main Methods:
- Experimentally induced mature subglottic stenosis in six canine models.
- Opened the induced SGS using CO2 laser.
- Treated experimental animals with penicillamine and N-acetyl-L-cysteine, comparing outcomes to control dogs over 5 weeks.
Main Results:
- Treated dogs showed a reduced rate of SGS re-stenosis compared to controls.
- One treated dog maintained complete airway patency throughout the 5-week treatment period.
- Histological analysis revealed severe cricoid collapse, necrosis, and scarring, mirroring human SGS.
Conclusions:
- Penicillamine and N-acetyl-L-cysteine show potential in reducing SGS reformation.
- These FDA-approved agents may serve as valuable adjunctive therapy in SGS surgical management.
- The canine model demonstrated histological similarities to human subglottic stenosis.